Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Quinolonyl-carbapenems from P&G

Oct. 4, 1996

Orally active ester-type carbapenem prodrug from Sankyo

Oct. 4, 1996

Novel carbapenem with anti-MRSA activity from Banyu

Oct. 4, 1996

Carbapenem from Merck & Co. undergoing extensive evaluation

Oct. 4, 1996

P&G describes quinolonyl-cephem dithiocarbamates

Oct. 4, 1996

Cephalosporin-bridged carbacephem combinations evaluated by Roche

Oct. 4, 1996

Combined beta-lactamase inhibitor/antibacterial agent from Roche

Oct. 4, 1996

Bridged carbacephems from Roche for use in combination with cephalosporins

Oct. 4, 1996

Fujisawa describes orally active cephalosporin

Oct. 4, 1996

Hydroxypyridone cephalosporins described by Kyorin

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...